Pd1 - OmicsDI

Browse
Submit Data
Databases
API
Help

4169 Results

Show all Save search Copy query

Show results for

Unknown (2477)
Genomics (919)
Transcriptomics (602)
Proteomics (70)
Clinical (33)
Other (30)
Metabolomics (23)
Methylation profiling (8)
Genomic (4)
Models (3)

Organisms

Mus musculus (397)
Homo sapiens (374)
Acidithiobacillus ferrooxidans ATCC 53993 (38)
Aerococcus urinae NBRC 15544 = CCUG 36881 (38)
Allexis (38)
Arabidopsis thaliana (38)
Cyanophora paradoxa (38)
Ensifer adhaerens (38)
Enterococcus faecalis (38)
Globicatella sanguinis (38)
Histomonas meleagridis (38)
Leishmania major strain Friedlin (38)
Listeria monocytogenes (38)
Lotus japonicus (38)
Marchantia polymorpha (38)
Medicago truncatula (38)
Methylohalobius crimeensis 10Ki (38)
Mus musculus (38)
Mycobacterium tuberculosis (38)
Macaca mulatta (5)
Marmota monax (1)
Aspergillus niger (1)
Taeniopygia guttata (1)
mouse gut metagenome (1)
Bos taurus (1)
Caenorhabditis elegans (1)
Ovis aries (1)
Canis lupus familiaris (1)
synthetic construct (1)
Escherichia coli (1)

Organisms

Mus musculus (392)
Homo sapiens (228)
Fervidibacter sacchari (25)
Macaca mulatta (3)
Phytobacter diazotrophicus (2)
unidentified (2)
human gut metagenome (2)
Neobacillus novalis (1)
Penicillium digitatum Pd1 (1)
Achromobacter sp. PD1 (1)
Pseudomonas putida (1)
Nematostella vectensis (1)
Mus musculus domesticus (1)
Canis lupus familiaris (1)
mouse gut metagenome (1)
Ovis aries (1)

Repository

ENA (804)
geo (509)
biostudies-arrayexpress (159)
EGA (83)
pride (38)
MetaboLights (16)
MassIVE (14)
iProX (11)
MetabolomicsWorkbench (7)
jPOST (6)
dbGaP (4)
BioModels (3)
EVA (2)
GPMDB (2)
PanoramaPublic (1)

Tissue

Cell culture (9)
Blood (7)
Melanocyte (5)
Skin (5)
T cell (5)
Blood serum (3)
Epithelial cell (3)
Blood (2)
Feces (2)
Lung (2)
Colon (1)
Blood cell (1)
Bone marrow (1)
Cell suspension culture (1)
Dendritic cell (1)
Early embryonic cell (1)
Hepatocyte (1)
Leukocyte (1)
Lymph node (1)
Mesenchymal stem cell (1)
Ovarian surface epithelial cell (1)
Peripheral blood mononuclear cell (1)
Serum (1)
Tibia (1)
Whole body (1)

Disease

Colorectal Neoplasms (15)
Melanoma (11)
Carcinoma (5)
Sarcoma (2)
Neoplasms (2)
Not Available (2)
Hepatocellular carcinoma (2)
Colorectal cancer with liver metastasis (1)
Liver Neoplasms (1)
Carcinoma, Renal Cell (1)
Lung Neoplasms (1)
Pancreatic Neoplasms (1)
Melanoma (1)
Neoplasm Metastasis (1)
Colorectal cancer (1)
Colorectal cancer (1)
Sepsis (1)
Cancer (1)
Acute leukemia (1)
Breast cancer (1)
Cervix carcinoma (1)
Colon cancer (1)
Esophagus squamous cell carcinoma (1)
Hepatoblastoma (1)
Lymphoma (1)
Malignant neoplasm of ovary (1)
Osteosarcoma (1)
Skin cancer (1)
Skin melanoma (1)

Technology Type

Mass Spectrometry (45)
Shotgun proteomics (16)
Bottom-up proteomics (9)
Mass spectrometry (8)
Mass spectrometry assay (8)
ESI (7)
Affinity purification coupled with mass spectrometry proteomics (7)
Data-independent acquisition (5)
Data-dependent acquisition (4)
Gel-based experiment (3)
Illumina HiSeq 2500, ILLUMINA (2)
Illumina Oncoscan Array (1)
Illumina HiSeq 2000, HiSeq X Ten, Illumina HiSeq 2500, ILLUMINA (1)
ILLUMINA, Illumina HiSeq 2500 (1)
Illumina HiSeq 2000 (1)
NMR spectroscopy assay (1)
NMR spectroscopy (1)
All-ion fragmentation (1)
Chemical cross-linking coupled with mass spectrometry proteomics (1)
SRM/MRM (1)
SWATH MS (1)
Top-down proteomics (1)

Instrument Platform

Illumina NovaSeq 6000 (17)
Illumina HiSeq 4000 (8)
Illumina HiSeq 2500 (7)
NextSeq 500 (7)
NextSeq 550 (4)
Q Exactive (4)
Orbitrap Fusion Lumos (3)
Instrument (2)
Orbitrap Eclipse (2)
NCounter Pro and nCounter Pro Analysis System (1)
Octo MACS Dissociator (1)
Fluidic station 450 and Affymetrix scanner 3000 (1)
MoFlo XDP (Beckman Coulter) or a FACSAria II (Becton Dickinson) (1)
Fluidigm C1 autoprep system (1)
Affymetrix Gene Titan (1)
Gene Titan (1)
Illumina NovaSeq X (1)
NA (1)
Sony MA900 (1)
FACS Aria (1)
Ion Torrent Proton (1)
NextSeq 2000 (1)
DNBSEQ-G400 (1)
DNBSEQ-T7 (1)
BGISEQ-500 (1)
Illumina HiSeq 2000 (1)
Illumina NextSeq 500 (1)
- (1)
6546 Q-TOF LC/MS (Agilent Instrument model) (1)
6550 iFunnel Q-TOF LC/MS (1)

Publication Date

2024 (128)
2025 (118)
2026 (91)
2023 (82)
2022 (68)
2021 (52)
2020 (42)
2016 (41)
2019 (20)
2018 (17)
2017 (17)
2015 (17)
2014 (17)
2012 (15)
2011 (10)
2013 (9)
2010 (8)
2008 (5)
2009 (1)
2007 (1)

UNIPROT ID/AC

Q13094 (1)
Q13588 (1)
Q9NZQ7 (1)
P20963 (1)
Q06124 (1)
O43561 (1)
P43403 (1)
P06239 (1)
P10747 (1)
P42336 (1)
P27986 (1)
P62993 (1)

CHEBI ID

CHEBI:71559 (1)
CHEBI:131889 (1)
CHEBI:157748 (1)
CHEBI:57614 (1)
CHEBI:140930 (1)
CHEBI:138249 (1)
CHEBI:138179 (1)
CHEBI:89570 (1)
CHEBI:137193 (1)
CHEBI:138640 (1)
CHEBI:157747 (1)
CHEBI:157745 (1)
CHEBI:138655 (1)
CHEBI:74067 (1)
CHEBI:91144 (1)
CHEBI:89582 (1)
CHEBI:34939 (1)
CHEBI:28031 (1)
CHEBI:88493 (1)
CHEBI:35032 (1)
CHEBI:36203 (1)
CHEBI:81565 (1)
CHEBI:17482 (1)
CHEBI:88347 (1)
CHEBI:21563 (1)
CHEBI:72786 (1)
CHEBI:88345 (1)
CHEBI:157746 (1)
CHEBI:73039 (1)
CHEBI:40521 (1)

Metabolite Name

Creatinine (5)
D-Ornithine (4)
L-Methionine (4)
PGE3 (3)
3-Hydroxymethylglutaric acid (3)
Bovinic acid (3)
20-HETE (3)
L-Norleucine (3)
Uracil (3)
Betaine (3)
Pyroglutamic acid (3)
1-Aminocyclopropanecarboxylic acid (3)
Pantothenol (3)
L-Homoserine (3)
7-Ketocholesterol (3)
L-Threonine (3)
Nicotinamide (3)
Choline (3)
Taurine (3)
Perillic acid (3)
L-Proline (3)
L-Lysine (3)
Gluconic acid (3)
Citric acid (3)
Myo-Inositol (3)
Adenosine (3)
Spermidine (3)
Histamine (3)
Cytosine (3)
N-Acetyl-L-phenylalanine (3)

First Public Date

2025 (160)
2024 (148)
2026 (108)
2023 (94)
2022 (76)
2021 (69)
2020 (53)
2019 (30)
2018 (21)
2017 (21)
2016 (11)
2014 (8)
2015 (4)
2013 (1)

Modelling Approach

Computational model (2)
Ordinary differential equation model (1)

Study status

Recruiting (15)
Completed (7)
Active, not recruiting (5)
Not yet recruiting (3)
Not provided (2)
Terminated (1)

Lab affiliation

State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou 510060, China (3)
Tumor Biology Department Molecular Medicine Program Moffitt Cancer Center Tampa, FL, USA (3)
Department of Human Molecular Genetics and Biochemistry, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel (2)
Department of Pathology and Cell Biology and Institute for Cancer Genetics Herbert Irving Comprehensive Cancer Vagelos College of Physicians & Surgeons Columbia University (2)
Cell Signalling and Immunology, School of Life Sciences, University of Dundee, Dundee (1)
Cutaneous Oncology and Immunology Moffitt Cancer Center Tampa, FL, USA (1)
Department of Biochemistry, Albert Einstein College of Medicine, Bronx, NY 10461, United States (1)
Department of Biology, Institute of Molecular Systems Biology, ETH Zurich, Zurich, Switzerland Faculty of Science, University of Zurich, Zurich, Switzerland (1)
Department of Immunobiology University of Lausanne Chemin des Boveresses 155 CH-1066 Epalinges, Switzerland (1)
Division of Hematology-Oncology, Department of Internal Medicine, Veterans Health Service Medical Center, Seoul 05368, Republic of Korea (1)
Division of Oncogenomics, Oncode institute, The Netherlands Cancer Institute, Plesmanlaan 121, 1066CX, Amsterdam, The Netherlands; (1)
Division of Pharmacology & Toxicology, Department of Pharmaceutical Sciences, Faculty of Life Sciences, University of Vienna (1)
Division of Pharmacology & Toxicology, Department of Pharmaceutical Sciences, University of Vienna (1)
ETH Zurich, Institute of Molecular Systems Biology, Zurich, Switzerland (1)
Experimental Systems Immunology Laboratory, Max-Planck Institute of Biochemistry, Martinsried, Germany. (1)
Head of Bioanalytics Group, Department of Environmental Toxicology (Utox), Eawag – Swiss Federal Institute of Aquatic Science and Technology, 8600 Duebendorf, Switzerland (1)
Institute Krems Bioanalytics, IMC University of Applied Sciences, 3500 Krems, Austria (1)
International Centre for Cancer Vaccine Science, University of Gdansk (1)
Medical Oncology Department, La Paz University Hospital (1)
Medical Oncology Service, Hospital Universitario La Paz, Madrid, Spain (1)
Moffitt Cancer Center Tampa, FL, USA (1)
Molecular Systems Immunology Group Turku Bioscience University of Turku P.O. Box 123, BioCity (Street adr. Tykistökatu 6 A, 7th floor) FIN-20521 Turku, Finland +358-40-718 4813 (Mobile) (1)
Molecular cell biology, Weizmann institute of science (1)
Qilu Hospital of Shandong University (1)
Regeneron Pharmaceuticals (1)
School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong SAR (1)
School of Pharmaceutical Science, Sun Yat-sen University, China (1)
Section/Core Facility Mass Spectrometry and Proteomics, University Medical Center Hamburg-Eppendorf (UKE), Martinistr. 52, 20246 Hamburg, Germany (1)
Tumor Biology Moffitt Cancer Center Tampa, FL, USA (1)
Univ. Bordeaux, INSERM, BRIC, U1312, Bordeaux, France (1)

Tags

xref:PubMed:36045296 (9)
xref:PubMed:41652589 (7)
xref:PubMed:40080526 (7)
xref:PubMed:40730154 (5)
xref:PubMed:37086018 (4)
xref:PubMed:39259785 (4)
xref:PubMed:39798567 (4)
xref:PubMed:39901247 (4)
xref:PubMed:38226976 (3)
xref:PubMed:41364533 (3)
xref:PubMed:32641748 (3)
xref:PubMed:38413714 (3)
xref:PubMed:39933899 (3)
xref:PubMed:28249162 (3)
xref:PubMed:30478422 (3)
xref:PubMed:38383563 (3)
xref:PubMed:40172969 (3)
xref:PubMed:40199327 (3)
xref:PubMed:34380768 (2)
xref:PubMed:31911474 (2)
xref:PubMed:35621713 (2)
xref:PubMed:34142094 (2)
xref:PubMed:40955658 (2)
xref:PubMed:41620448 (2)
xref:PubMed:29296022 (2)
xref:PubMed:41271647 (2)
xref:PubMed:35051357 (2)
xref:PubMed:36555441 (2)
xref:PubMed:36423635 (2)
xref:PubMed:37219874 (2)

Keyword

Pembrolizumab (7)
Nivolumab (7)
Capecitabine (6)
Immunotherapy (5)
Bevacizumab (5)
PD1 (4)
Oxaliplatin (4)
Cetuximab (4)
Durvalumab (3)
Ipilimumab (3)
Antibodies (3)
Irinotecan (3)
RCC (2)
Tislelizumab (2)
TNBC (2)
PD-1 (2)
Gemcitabine (2)
Avelumab (2)
Leucovorin (2)
LILRB2 (1)
CD85d (1)
ILT-4 (1)
Bi-Specific (1)
Solid tumor Malignancies (1)
Immunological (1)
CTLA4 antibody (1)
PD1 antibody (1)
PDL1 antibody (1)
Interventional Radiology (1)
Trans-artery infusion (1)

IsPrivate

False (3)

Submitter Keywords

FAIR-AIML (2)
Machine Learning Model (2)

Classification

bacteria (2)

Study type

Transcription profiling by array (89)
Interventional (31)
RNA-seq of coding RNA (29)
RNA-seq of coding RNA from single cells (21)
ChIP-seq (4)
RNA-seq of total RNA (3)
Human - One-color microarray (2)
Comparative genomic hybridization by array (2)
Differential (1)
Human - Single-cell sequencing (1)
Human - High-throughput sequencing (1)
High-throughput sequencing (1)
Animal - High-throughput sequencing (1)
Genotyping by array (1)
DNA-seq (1)
Methylation profiling by array (1)
RNA-seq of non coding RNA (1)
Other (1)
Observational patient registry (1)

Release Date

2022 (422)
2023 (345)
2021 (338)
2024 (331)
2025 (319)
2020 (264)
2019 (140)
2018 (121)
2016 (82)
2017 (73)
2015 (48)
2026 (38)
2014 (38)
2013 (20)
2012 (16)
2011 (13)
2010 (11)
2008 (7)
2009 (4)
2007 (4)
2005 (1)
2002 (1)

Location

United States (11)
China (10)
France (8)
Australia (3)
Hong Kong (2)
United Kingdom (2)
South Korea (2)
Spain (2)
Belgium (2)
Germany (2)
New Zealand (1)
Singapore (1)
Taiwan (1)
Chile (1)
Poland (1)
Russia (1)
Italy (1)
Canada (1)
Austria (1)
Netherlands (1)

Previous page
1 / 417
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 417
Next page

Sort by:

Relevance

Page size

10

Mass Spectrometry-Driven Epitope Mapping: Application of Diethylpyrocarbonate Covalent Labeling for the Immunotherapeutic Target Programmed Cell Death Protein 1

Monoclonal antibodies (mAbs) have transformed cancer immunotherapy, with anti-PD1 mAbs playing a pivotal role. This study introduces diethylpyrocarbonate covalent labeling-mass spectrometry (DEPC CL-MS) as a rapid and sensitive technique for epitope mapping of PD1, a critical target in mAb developme...

ORGANISM(S): Homo Sapiens (ncbitaxon:9606)

2024-11-26 | MSV000096536 | MassIVE

Single-cell characterization of anti-LAG3+anti-PD1 treatment in melanoma patients

We evaluated blood samples from 6 patients with metastatic melanoma treated with anti-LAG3+anti-PD1 (160+480 mg) in a phase I trial (NCT01968109) using single-cell RNA and T cell receptor (TCR) sequencing (scRNA+TCRαβ-seq, 10X 5') combined with other multiomics profiling (flow, cytokine, TCRb-seq) f...

ORGANISM(S): Homo sapiens

2023-02-03 | E-MTAB-12733 | biostudies-arrayexpress

Achromobacter sp. PD1

Achromobacter sp. PD1 Genome sequencing

PRJNA1221536 | ENA

Fervidibacter sacchari strain:PD1

Fervidibacter sacchari PD1 genome sequencing

PRJNA834363 | ENA

Penicillium digitatum Pd1

Genome Sequencing of Penicillium digitatum Pd1

PRJNA157543 | ENA

Fervidibacter sacchari strain:PD1

Fervidibacter sacchari PD1 transcriptome - F.sacchari_St1

PRJNA1384502 | ENA

Fervidibacter sacchari strain:PD1

Fervidibacter sacchari PD1 transcriptome - F.sacchari_XG1

PRJNA1384384 | ENA

Fervidibacter sacchari strain:PD1

Fervidibacter sacchari PD1 transcriptome - F.sacchari_XG3

PRJNA1385673 | ENA

Fervidibacter sacchari strain:PD1

Fervidibacter sacchari PD1 transcriptome - F.sacchari_St2

PRJNA1384483 | ENA

Fervidibacter sacchari strain:PD1

Fervidibacter sacchari PD1 transcriptome - F.sacchari_St3

PRJNA1385100 | ENA

Previous page
1 / 417
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 417
Next page

Sort by:

Relevance

Page size

10

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data